SKI Market

A+| A| A-|

Indian Indices

Sensex

77,958.52 940.73
( 1.22%)

Global Indices

Nasdaq

49,315.95 353.04
(0.72%)

Dow Jones

7,281.26 59.51
(0.82%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,219.44 -144.49
(-1.39%)

Forex

USD-INR

95.09 0.27
(0.28%)

EUR-INR

111.34 0.19
(0.17%)

GBP-INR

128.90 0.20
(0.16%)

JPY-INR

0.61 0.00
(0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Emcure Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

544210

INE168P01015

169.4916517

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EMCURE

48.26

32068.12

EPS(TTM)

Face Value()

Div & Yield %

35.05

Back

mphasis ltd

NELCO reports consolidated net profit of Rs 1.09 crore in the March 2026 quarter

Apr 21,2026

Net profit of NELCO reported to Rs 1.09 crore in the quarter ended March 2026 as against net loss of Rs 4.08 crore during the previous quarter ended March 2025. Sales rose 17.27% to Rs 79.18 crore in the quarter ended March 2026 as against Rs 67.52 crore during the previous quarter ended March 2025.

For the full year,net profit declined 65.16% to Rs 3.32 crore in the year ended March 2026 as against Rs 9.53 crore during the previous year ended March 2025. Sales rose 0.57% to Rs 306.60 crore in the year ended March 2026 as against Rs 304.87 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	79.18	67.52	17	306.60	304.87	1
OPM %	6.91	9.54	-	9.32	13.77	-
PBDT	6.67	7.56	-12	28.35	41.82	-32
PBT	1.75	1.13	55	8.40	19.66	-57
NP	1.09	-4.08	LP	3.32	9.53	-65

77,958.52 940.73 ( 1.22%)

49,315.95 353.04 (0.72%)

7,281.26 59.51 (0.82%)

59,594.47 309.55 (0.52%)

10,219.44 -144.49 (-1.39%)

95.09 0.27 (0.28%)

111.34 0.19 (0.17%)

128.90 0.20 (0.16%)

0.61 0.00 (0.29%)